NAFLD/NASH patients show increases in established hepatocellular senescence markers, including cell cycle arrest (p21) and phosphorylation of histone H2AX (γ-H2AX), which correlate with the severity of the disease [14–16]. Here, CDKN1A is linked to metabolic dysfunction-associated steatotic liver disease.